Patents-Review.com
ClassID:

20512 ⎘

A61K31/7008 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine

Recent Application in this class:
#1
20260146252
2026-05-28

COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS

 #2
20260130931
2026-05-14

ENERGY DRINK COMPOSITION

 #3
20260109699
2026-04-23

AZOLE DERIVATIVES AS SHP2 INHIBITORS

 #4
20260097055
2026-04-09

COGNITION

 #5
20260083829
2026-03-26

High Concentration Alpha-Glucosidase Compositions For The Treatment Of Pompe Disease

 #6
20260069659
2026-03-12

TREATMENT OF CONNECTIVE TISSUE INJURIES

 #7
20260041707
2026-02-12

GASTROINTESTINAL PROTECTANT COMPOSITION

 #8
20260031214
2026-01-29

SYSTEMS FOR GENERATING PERSONALIZED DIETARY SUPPLEMENTS

 #9
20260027071
2026-01-29

COMPOSITION FOR PROMOTING COLLAGEN PRODUCTION COMPRISING AMIDATED AMINO ACID

 #10
20260014193
2026-01-15

COMPOSITIONS AND METHODS FOR DEGENERATIVE DISC REGENERATION

 #11
20250375463
2025-12-11

NUTRACEUTICAL COMPOSITION FOR COMBATING AGING IN HUMAN AND NON-HUMAN ANIMALS AND BEVERAGES AND/OR FOOD PRODUCTS AND/OR FOOD SUPPLEMENTS CONTAINING THE SAME

 #12
20250375462
2025-12-11

NUTRACEUTICAL COMPOSITION FOR COMBATING AGING IN HUMAN AND NON-HUMAN ANIMALS AND BEVERAGES AND/OR FOOD PRODUCTS AND/OR FOOD SUPPLEMENTS CONTAINING THE SAME

 #13
20250275993
2025-09-04

GLYCOSYLATION INHIBITORS AS THERAPEUTICS FOR STROKE

 #14
20250275941
2025-09-04

COMPOSITIONS AND METHODS FOR TREATING EPILEPSY, SEIZURES AND OTHER CONDITIONS

 #15
20250228957
2025-07-17

BIFUNCTIONAL DEGRADERS OF GALACTOSE-DEFICIENT IMMUNOGLOBULINS

 #16
20250222071
2025-07-10

TREATMENT OF CONNECTIVE TISSUE INJURIES

 #17
20250186449
2025-06-12

COMPOSITIONS AND METHODS FOR TREATING A V-ATPASE MALFUNCTION

 #18
20250186338
2025-06-12

Stable Soft Chews, and Methods to Produce Same

 #19
20250170156
2025-05-29

TOLL-LIKE RECEPTOR LIGANDS

 #20
20250154188
2025-05-15

C-GLYCOSIDES AS ANTI-INFLAMMATORY AGENTS

 #21
20250135164
2025-05-01

Controlled Release Of A Hydrophilic Agent From A Coated Surface

 #22
20250114386
2025-04-10

COMBINATION OF A GLYCOSYLATION INHIBITOR WITH ONE CAR CELL THERAPY FOR TREATING CANCER

 #23
20250099510
2025-03-27

METHODS FOR TREATING SUBCLINICAL MASTITIS IN RUMINANTS

 #24
20250090449
2025-03-20

Foamed Microtablets for Oral Delivery of Active Ingredients

 #25
20250073233
2025-03-06

MODULATORS OF RAR-RELATED ORPHAN RECEPTORS (RORs)

 #26
20250032522
2025-01-30

A Formulated And Synthesised Edible Birds Nest And Milk Based Nutritional Product And Methods For Preparation Thereof

 #27
20250032521
2025-01-30

COGNITION

 #28
20250025492
2025-01-23

DERIVATIZED CHITOSAN POLYMERS AND METHODS OF TREATING VASCULAR DISORDERS

 #29
20240415858
2024-12-19

PROMOTING MYELINATION BY N-ACETYLGLUCOSAMINE AND MODULATION OF N-GLYCAN BRANCHING

 #30
20240335490
2024-10-10

COMPOSITION FOR PREVENTING OR AMELIORATING LOCOMOTIVE SYNDROME

 #31
20240325430
2024-10-03

MULTIPLE FOLATE FORMULATION AND USE THEREOF

 #32
20240325337
2024-10-03

TETRAHYDROCURCUMINOID-METAL COMPLEXES, MANUFACTURING METHODS THEREOF, AND USES THEREOF

 #33
20240293436
2024-09-05

Methods Of Treating Fabry Disease In Patients Having A Mutation In The GLA Gene

 #34
20240277656
2024-08-22

Compositions and methods for treating epilepsy, seizures and other conditions

 #35
20240207295
2024-06-27

Methods Of Treating Fabry Disease In Patients Having A Mutation In The GLA Gene

 #36
20240131103
2024-04-25

NOVEL ARTHRITIS EMULGEL COMPOSITION AND ITS PREPARATION PROCESS

 #37
20240099976
2024-03-28

BLENDED FORMULATIONS

 #38
20240093201
2024-03-21

COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS

 #39
20240091243
2024-03-21

METHODS FOR PREVENTING VIRAL INFECTION

 #40
20240041799
2024-02-08

Agmatine compositions for treatment of osteoarthritis

 #41
20240024310
2024-01-25

CARBOSTYRIL DERIVATIVES AND MOOD STABILIZERS FOR TREATING MOOD DISORDERS

 #42
20240009273
2024-01-11

Treatment of connective tissue injuries

 #43
20230399353
2023-12-14

Amino acid derivative of glucosamine stimulating extracellular matrix synthesis and pharmaceutical composition comprising the same

 #44
20230398178
2023-12-14

METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING A VAGINAL INFECTION OF GARDNERELLA VAGINALIS

 #45
20230390315
2023-12-07

COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC CONDITIONS

 #46
20230364071
2023-11-16

Dosing Regimens for the Treatment of Lysosomal Storage Diseases Using Pharmacological Chaperones

 #47
20230355574
2023-11-09

Compositions and methods for treating epilepsy, seizures and other conditions

 #48
20230346894
2023-11-02

FORMULATION WITH CANNABINOIDS

 #49
20230346816
2023-11-02

COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTION

 #50
20230330065
2023-10-19

RelA Inhibitors for Biofilm Disruption

 #51
20230329313
2023-10-19

METHODS OF MAKING NON-AQUEOUS CHEWS

 #52
20230321065
2023-10-12

Treatment Of Fabry Disease In ERT-Naïve And ERT-Experienced Patients

 #53
20230285432
2023-09-14

Pharmaceutical composition, methods for treating and uses thereof

 #54
20230285316
2023-09-14

Extended release plastic formulation

 #55
20230270795
2023-08-31

GUT MICROBIOTA AND TREATMENT OF CANCER

 #56
20230270762
2023-08-31

TOPICAL COMPOSITION FOR THE TREATMENT OF PSORIASIS AND RELATED SKIN DISORDERS

 #57
20230263179
2023-08-24

INFANT FORMULA MILK POWDER RICH IN MILK FAT GLOBULE MEMBRANE PROTEIN, PHOSPHOLIPIDS AND OLIGOSACCHARIDES AND PREPARATION METHOD THEREFOR

 #58
20230240988
2023-08-03

FLUID GEL COMPOSITIONS

 #59
20230233522
2023-07-27

Compositions and methods for treating epilepsy, seizures and other conditions

 #60
20230225979
2023-07-20

SOLID ORAL COMPOSITIONS COMPRISING COMPOSITE MONOLITHIC MATRICES FOR CHRONOTROPIC ADMINISTRATION OF ACTIVE INGREDIENTS IN THE GASTROINTESTINAL TRACT

 #61
20230190852
2023-06-22

COMPOSITIONS AND METHODS FOR JOINT HEALTH

 #62
20230130134
2023-04-27

METHOD OF TREATING VIRAL INFECTIONS WITH HEXOSE TYPE MONOSACCHARIDES AND ANALOGS THEREOF

 #63
20230121154
2023-04-20

COMPOSITIONS AND METHODS FOR DEGENERATIVE DISC REGENERATION

 #64
20230085573
2023-03-16

Compositions and Methods for Treating Aging-Related Disorders

 #65
20230082005
2023-03-16

TREATMENT OF CONNECTIVE TISSUE INJURIES

 #66
20230060588
2023-03-02

METHODS OF AMELIORATING AND/OR PREVENTING CORONAVIRUS-RELATED INFECTIONS

 #67
20230055805
2023-02-23

Toll-like receptor ligands

 #68
20230049572
2023-02-16

FORMULATION, COMPOSITION OR FOODSTUFF ADDITIVES FOR THE MODIFICATION OF GLYCEMIC RESPONSE METHODS OF MANUFACTURING AND USING THE SAME

 #69
20230048900
2023-02-16

Extended release plastic formulation

 #70
20220401400
2022-12-22

Compositions and methods for treating epilepsy, seizures and other conditions

 #71
20220395522
2022-12-15

Methods of Use of Glucosamine for Increasing Nitrogen Retention

 #72
20220387462
2022-12-08

Use Of Migalastat For Treating Fabry Disease In Pregnant Patients

 #73
20220387450
2022-12-08

COMPOSITION FOR PREVENTING OR TREATING DIABETES MELLITUS

 #74
20220378751
2022-12-01

INHIBITING DIHYDROFOLATE REDUCTASE IN A MICROORGANISM

 #75
20220370353
2022-11-24

BLENDED FORMULATIONS

 #76
20220347272
2022-11-03

HIGH CONCENTRATION ALPHA-GLUCOSIDASE COMPOSITIONS FOR THE TREATMENT OF POMPE DISEASE

 #77
20220339176
2022-10-27

Methods of Treatments to Prolong Gestation and Complications of Menstruation or Gestation

 #78
20220296713
2022-09-22

BIOPHOTONIC COMPOSITIONS FOR TREATING SKIN AND SOFT TISSUE WOUNDS HAVING EITHER OR BOTH NON-RESISTANT AND RESISTANT INFECTIONS

 #79
20220296625
2022-09-22

CANCER CHEMOTHERAPY SUPPORTING AGENT, FOOD, AND DRUG

 #80
20220280579
2022-09-08

Formulations for Prevention or Reduction of C. Difficile Infections

 #81
20220273688
2022-09-01

Treatment of Glycosylation Deficiency Diseases

 #82
20220257625
2022-08-18

COMPOSITION AND METHODS FOR THE TREATMENT OF SKIN CONDITIONS

 #83
20220241362
2022-08-04

Multi-efficacy traditional chinese medicine compound composition and application thereof in pharmaceutical preparations

 #84
20220218832
2022-07-14

POLYMER DRUG

 #85
20220218761
2022-07-14

MONITORING AND ALTERING THE GUT MICROBIOME IN DISEASE

 #86
20220211733
2022-07-07

Compositions and products for infectious or inflammatory diseases or conditions

 #87
20220160754
2022-05-26

Derivatized chitosan polymers and methods of treating vascular disorders

 #88
20220079935
2022-03-17

COMPOUNDS AND TREATMENTS THAT ENHANCE ENTERIC NERVOUS SYSTEM FUNCTION

 #89
20220040269
2022-02-10

Pet food formulation with cannabinoids

 #90
20220033817
2022-02-03

Targeting Ligands

 #91
20220031718
2022-02-03

GLUCOSE INFUSION SOLUTION COMPOSITION

 #92
20220031681
2022-02-03

Dosing Regimens for the Treatment of Lysosomal Storage Diseases Using Pharmacological Chaperones

 #93
20220023325
2022-01-27

SPECIFIC TLR4 ANTAGONIST IN THE TREATMENT OF MULTIPLE MYELOMA

 #94
20220023181
2022-01-27

PEROXIDE-LESS BIOPHOTONIC COMPOSITIONS AND METHODS

 #95
20220016183
2022-01-20

EXOSOME AND VARIOUS USES THEREOF

 #96
20220000864
2022-01-06

MODULATORS OF RAR-RELATED ORPHAN RECEPTORS (RORs)

 #97
20210386834
2021-12-16

COLLAGEN REPLACEMENT/REGENERATION FORMULATION AND USES THEREOF

 #98
20210353664
2021-11-18

Compositions and methods comprising growth factors, chondroitin and glucosamine for degenerative disc regeneration

 #99
20210353658
2021-11-18

COMPOSITION AND METHOD OF INHIBITING CORTISONE REDUCTASE

 #100
20210353583
2021-11-18

TETRAHYDROCURCUMINOID-METAL COMPLEXES, MANUFACTURING METHODS THEREOF, AND USES THEREOF

 #101
20210347803
2021-11-11

Amino acid derivative of glucosamine stimulating extracellular matrix synthesis and pharmaceutical composition comprising the same

 #102
20210346415
2021-11-11

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

 #103
20210317458
2021-10-14

POLYNUCLEOTIDE AGENTS TARGETING PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) AND METHODS OF USE THEREOF

 #104
20210315922
2021-10-14

Compositions and methods for degenerative disc regeneration

 #105
20210308162
2021-10-07

NOVEL TLR4 INHIBITORS FOR THE TREATMENT OF HUMAN INFECTIOUS AND INFLAMMATORY DISORDERS

 #106
20210308160
2021-10-07

N-palmitoyl-D-glucosamine in a micronized form

 #107
20210308126
2021-10-07

CARBOSTYRIL DERIVATIVES AND MOOD STABILIZERS FOR TREATING MOOD DISORDERS

 #108
20210290646
2021-09-23

COMBINATION OF A GLYCOSYLATION INHIBITOR WITH ONE CAR CELL THERAPY FOR TREATING CANCER

 #109
20210283417
2021-09-16

Methods and compositions for reversing or mitigating skin aging

 #110
20210275556
2021-09-09

Cannabidiol Combination Compositions

 #111
20210267934
2021-09-02

CANNABINOID ORAL DISPERSIBLE FILM STRIP

 #112
20210228483
2021-07-29

LOW GLYCEMIC GUMMY COMPOSITION AND METHODS OF MAKING AND USING THEREOF

 #113
20210221836
2021-07-22

IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS

 #114
20210219589
2021-07-22

CANNABINOID EMULSION PRODUCT AND PROCESS FOR MAKING THE SAME

 #115
20210178129
2021-06-17

Controlled release of a hydrophilic agent from a coated surface

 #116
20210161950
2021-06-03

Veterinary Supplement for Effecting Bone and Cartilage

 #117
20210137911
2021-05-13

NOVEL CHRONOTHERAPY BASED ON CIRCADIAN RHYTHMS

 #118
20210137832
2021-05-13

Composition and method for orally administering one or more active agents to a pet

 #119
20210132089
2021-05-06

Method for diagnosing risk for inflammatory disease through glycan profiling

 #120
20210128594
2021-05-06

Compositions and methods for treatment of inflammatory disorders

 #121
20210128493
2021-05-06

Pet Food Supplement

 #122
20210113609
2021-04-22

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING PROTEINURIA AND ENDOTHELIAL EROSION

 #123
20210113469
2021-04-22

SUSTAINED RELEASE COMPOSITIONS USING WAX-LIKE MATERIALS

 #124
20210069221
2021-03-11

MATERIALS AND METHODS FOR SUPPRESSING AND/OR TREATING BACTERIAL INFECTIONS AND RELATED SYMPTOMS

 #125
20210046120
2021-02-18

THROMBOSOMES AS AN ANTICOAGULANT REVERSAL AGENT

 #126
20210038625
2021-02-11

Methods of treating Fabry disease in patients having a mutation in the GLA gene

 #127
20210038624
2021-02-11

Use of migalastat for treating Fabry disease in pregnant patients

 #128
20210023106
2021-01-28

Toll-like receptor ligands

 #129
20210023007
2021-01-28

BLENDED FORMULATIONS

 #130
20210007989
2021-01-14

Multiphasic compositions

 #131
20200390844
2020-12-17

PAIN RELIEVING SYSTEM

 #132
20200376121
2020-12-03

BIOPHOTONIC COMPOSITIONS, METHODS, AND KITS FOR PAIN RELIEF

 #133
20200345816
2020-11-05

Formulation with cannabinoids

 #134
20200339619
2020-10-29

Monosaccharide amine and 3-nitro-2-phenyl-2H-chromene based inhibitors of glucose kinases

 #135
20200330783
2020-10-22

Methods and compositions for treatment of pigmented lesions

 #136
20200291410
2020-09-17

Construction and application of engineering bacteria capable of secreting and expressing diacetylchitobiose deacetylase

 #137
20200262858
2020-08-20

Derivatives of amphotericin B

 #138
20200261497
2020-08-20

Iodinated Contract Medium for Use as a Medicament for Thyroid Radioprotection

 #139
20200248188
2020-08-06

POLYNUCLEOTIDE AGENTS TARGETING PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) AND METHODS OF USE THEREOF

 #140
20200246332
2020-08-06

CARBOSTYRIL DERIVATIVES AND MOOD STABILIZERS FOR TREATING MOOD DISORDERS

 #141
20200237805
2020-07-30

Compound composition with function of promoting bone and joint health and application thereof

 #142
20200230101
2020-07-23

Biophotonic compositions for the treatment of otitis externa

 #143
20200188494
2020-06-18

High concentration alpha-glucosidase compositions for the treatment of Pompe disease

 #144
20200179421
2020-06-11

Methods and compositions for preventing and treating conditions related to alpha-synuclein

 #145
20200157548
2020-05-21

COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS

 #146
20200138949
2020-05-07

Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease

 #147
20200138839
2020-05-07

GLUCOSE INFUSION SOLUTION COMPOSITION

 #148
20200138705
2020-05-07

PECTIN GUMMY COMPOSTION AND METHODS OF MAKING AND USING THEREOF

 #149
20200085855
2020-03-19

DEVICE AND METHOD TO TREAT OR PREVENT JOINT DEGENERATION

 #150
20200085851
2020-03-19

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

 #151
20200069776
2020-03-05

Pet food formulation with cannabinoids

 #152
20200069647
2020-03-05

RelA inhibitors for biofilm disruption

 #153
20200069564
2020-03-05

Topical compositions comprising and n-acetyl glucosamine

 #154
20200060975
2020-02-27

COMPOSITION FOR DISINTEGRATING TABLETS CONTAINING MICROFIBROUS CELLULOSE AND ACTIVE INGREDIENT

 #155
20200046747
2020-02-13

SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS

 #156
20200046007
2020-02-13

Cannabinoid emulsion product and process for making the same

 #157
20200038422
2020-02-06

A COMPOSITION WITH MOBILITY BENEFITS IN AGEING, HEALTHY SUBJECTS

 #158
20200030349
2020-01-30

PHYSIOLOGICALLY ACTIVE PREPARATION COMPRISING N-ACETYL-GLUCOSAMINE FOR THE TREATMENT OF BACK PAIN

 #159
20190388447
2019-12-26

Glycan-based drugs, therapies and biomarkers

 #160
20190380912
2019-12-19

Excipient free N-Acetyl glucosamine tablets and method of making

 #161
20190375776
2019-12-12

IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS

 #162
20190374566
2019-12-12

COMPOSITION FOR PREVENTING AND TREATING ARTHRITIS, INCLUDING DNA FRAGMENT MIXTURE AND MATRIX METALLOPROTEINASE PRODUCTION INHIBITOR

 #163
20190374562
2019-12-12

TLR4 inhibitors for the treatment of human infectious and inflammatory disorders

 #164
20190374561
2019-12-12

N-acetyl mannosammine as a therapeutic agent

 #165
20190366113
2019-12-05

Combination of an oxidant and a photoactivator for the wounds

 #166
20190365829
2019-12-05

Gut microbiota and treatment of cancer

 #167
20190358191
2019-11-28

Compositions containing omega-3 oil and uses thereof

 #168
20190358158
2019-11-28

Composition and method for orally administering one or more active agents to a pet

 #169
20190350968
2019-11-21

Compositions and methods for degenerative disc regeneration

 #170
20190338042
2019-11-07

METHODS OF TREATMENT

 #171
20190336428
2019-11-07

Prebiotic oral care methods using a saccharide

 #172
20190321382
2019-10-24

Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

 #173
20190314323
2019-10-17

REDUCTION OF GASTROINTESTINAL TRACT COLONISATION BY CAMPYLOBACTER

 #174
20190307859
2019-10-10

Enzyme-rich malt extract (ERME) formulations

 #175
20190307828
2019-10-10

DIETARY VEGAN SUPPLEMENT FOR TREATING JOINT PAIN

 #176
20190290669
2019-09-26

N-PALMITOYL-D-GLUCOSAMINE IN A MICRONIZED FORM

 #177
20190269777
2019-09-05

Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease

 #178
20190256849
2019-08-22

Targeting ligands

 #179
20190247425
2019-08-15

RUNX inhibitor

 #180
20190247410
2019-08-15

Anti-bacterial applications of poly-N-acetylglucosamine nanofibers

 #181
20190183869
2019-06-20

Treatment of Fabry disease in ERT-naïve and ERT-experienced patients

 #182
20190175680
2019-06-13

COMPOSITIONS COMPRISING NANOPARTICLES DERIVED FROM WHOLE FRUIT

 #183
20190167715
2019-06-06

Compositions and methods for treating and preventing proteinuria and endothelial erosion

 #184
20190160084
2019-05-30

METHODS FOR THE TREATMENT OF CANCER USING MEGLUMINE

 #185
20190151396
2019-05-23

Compositions useful in the prevention and/or treatment of osteoarticular inflammation and pain and cartilage damage

 #186
20190143137
2019-05-16

Methods and compositions for treatment of pigmented lesions

 #187
20190105334
2019-04-11

Anti-Viral Azide Containing Compounds

 #188
20190099440
2019-04-04

Method for olfactory improvement with saccharide

 #189
20190083447
2019-03-21

REDUCTION OF GASTROINTESTINAL TRACT COLONISATION BY CAMPYLOBACTER

 #190
20190054047
2019-02-21

TREATMENT OF MALIGNANT ADRENOCORTICAL TUMOR WITH NICLOSAMIDE AND OTHER COMPOUNDS

 #191
20190046548
2019-02-14

Formulation and Manufacturing Method for Color-Changing Eyedrops

 #192
20190038648
2019-02-07

Materials and methods for suppressing and/or treating bacterial infections and related symptoms

 #193
20190029994
2019-01-31

Biophotonic compositions for the treatment of otitis externa

 #194
20190022219
2019-01-24

Biophotonic compositions for treating skin and soft tissue wounds having either or both non-resistant and resistant infections

 #195
20190021995
2019-01-24

FORMULATION FOR TREATMENT OF PERIPHERAL JOINTS, SPINAL JOINTS AND/OR EXTRACELLULAR MATRIX ELEMENTS OF CONNECTIVE TISSUE, METHOD OF MANUFACTURE AND USES

 #196
20190021973
2019-01-24

Peroxide-less biophotonic compositions and methods

 #197
20190008884
2019-01-10

Methods and pharmaceutical compositions for modulating autophagy in a subject in need thereof

 #198
20180369261
2018-12-27

Use of N-acetylglucosamine and derivatives thereof to treat muscle disorders

 #199
20180360928
2018-12-20

High concentration alpha-glucosidase compositions for the treatment of pompe disease

 #200
20180360814
2018-12-20

Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones

 #201
20180360813
2018-12-20

Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones

 #202
20180360812
2018-12-20

Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones

 #203
20180311272
2018-11-01

Compositions and methods for treating joints

 #204
20180311148
2018-11-01

Multiphasic compositions

 #205
20180296684
2018-10-18

TARGETED THERAPEUTIC NUCLEOSIDES AND THEIR USE

 #206
20180296585
2018-10-18

Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

 #207
20180289735
2018-10-11

COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING HYALURONIC ACID AND EGGSHELL MEMBRANE COMPONENTS

 #208
20180289730
2018-10-11

AGENT FOR APPLYING TO MUCOSA AND METHOD FOR THE PRODUCTION THEREOF

 #209
20180280418
2018-10-04

Compositions and methods for treatment of inflammatory disorders

 #210
20180250326
2018-09-06

Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin

 #211
20180237419
2018-08-23

Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

 #212
20180235998
2018-08-23

Derivatized chitosan polymers and methods of treating vascular disorders

 #213
20180235988
2018-08-23

Sialylation-increasing therapies for diseases associated with oxidative stress

 #214
20180201936
2018-07-19

Polynucleotide agents targeting patatin-like phospholipase domain containing 3 (PNPLA3) and methods of use thereof

 #215
20180186899
2018-07-05

COMPOSITIONS OF PARTIALLY DEACETYLATED CHITIN DERIVATIVES

 #216
20180179249
2018-06-28

Method of making a hydrolyzed collagen gel

 #217
20180169137
2018-06-21

Compositions and methods comprising growth factors, chondroitin and glucosamine for degenerative disc regeneration

 #218
20180125974
2018-05-10

Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria

 #219
20180117072
2018-05-03

N-acetyl mannosammine as a therapeutic agent

 #220
20180099003
2018-04-12

Anti-bacterial applications of poly-N-acetylglucosamine nanofibers

 #221
20180094014
2018-04-05

Method of producing epirubicin and novel production intermediate thereof

 #222
20180085385
2018-03-29

GLUCOSE-SENSITIVE CELL PROTECTING AGENT

 #223
20180078618
2018-03-22

SYNERGISTIC GLYCOCALYX TREATMENT COMPOSITIONS AND METHODS

 #224
20180064819
2018-03-08

Targeting ligands

 #225
20180064742
2018-03-08

PET IMAGING TRACER FOR IMAGING PROSTATE CANCER

 #226
20180055874
2018-03-01

Fast acting joint relief formulations

 #227
20180055865
2018-03-01

Methods for determining the level of hyposialylation of Angptl4

 #228
20180038848
2018-02-08

Method for determining sensitivity to fluorouracil in a subject having colorectal cancer

 #229
20180036323
2018-02-08

Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children

 #230
20180016321
2018-01-18

Method of producing collagen from hydrolyzed egg membrane

 #231
20170360882
2017-12-21

COMPOSITION FOR PREVENTING, IMPROVING OR TREATING PSORIASIS COMPRISING IMMUNOMODULATOR AND GLUCOSAMINE

 #232
20170360867
2017-12-21

Pain Relieving System

 #233
20170354670
2017-12-14

PRODUCT COMPRISING GLUCOSAMINE FOR EXTERNAL APPLICATION

 #234
20170348272
2017-12-07

COMPOSITIONS CONTAINING OMEGA-3 OIL AND USES THEREOF

 #235
20170333463
2017-11-23

COMPOSITIONS AND FORMULATIONS OF GLUCOSAMINE FOR TRANSDERMAL AND TRANSMUCOSAL ADMINISTRATION

 #236
20170333457
2017-11-23

Anti-viral azide containing compounds

 #237
20170326170
2017-11-16

Method of treating a patient with a disease caused by a pathogenic mechanism associated with accumlation of methylglyoxal

 #238
20170326167
2017-11-16

Compositions and Methods for Treating an Infection

 #239
20170304351
2017-10-26

COMBINATION THERAPY FOR THE TREATMENT OF DEPRESSION AND OTHER NON-INFECTIOUS DISEASES

 #240
20170275326
2017-09-28

IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS

 #241
20170274045
2017-09-28

Sugar compositions for treating hemophilia A and/or Von Willebrand disease

 #242
20170274002
2017-09-28

MULTIPLE FOLATE FORMULATION AND USE THEREOF

 #243
20170258728
2017-09-14

Cellulose micropowder

 #244
20170246149
2017-08-31

Compositions and methods for treating microbial infections

 #245
20170232034
2017-08-17

METHOD TO ALLEVIATE JOINT PAIN USING LOW MOLECULAR WEIGHT HYALURONIC ACID AND JOINT CARE COMPONENTS, INCLUDING TYPE II COLLAGEN

 #246
20170231945
2017-08-17

Reduction of gastrointestinal tract colonisation by

#247
20170202898
2017-07-20

HERBAL OINTMENT FOR MUSCULOSKELETAL AND JOINT-RELATED CONDITIONS

 #248
20170189377
2017-07-06

Chlorophyll c containing degranulation suppressor

 #249
20170173062
2017-06-22

Compositions and methods for treating an infection

 #250
20170165284
2017-06-15

Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

 #251
20170157254
2017-06-08

Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease

 #252
20170151276
2017-06-01

METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS

 #253
20170151152
2017-06-01

COMBINATION OF N-ACETYL GLUCOSAMINE WITH ABSCISIC ACID AND USES THEREOF

 #254
20170143989
2017-05-25

Combination of an oxidant and a photoactivator for the healing of wounds

 #255
20170112948
2017-04-27

Inorganic-organic hybrid compound

 #256
20170112885
2017-04-27

Herbal formulations of carnivorous plants and methods for treating inflammation

 #257
20170095493
2017-04-06

TLR4 inhibitors for the treatment of human infectious and inflammatory disorders

 #258
20170080004
2017-03-23

Depression treatment agent

 #259
20170067897
2017-03-09

Method of treatment employing cardiac glycoside

 #260
20170056483
2017-03-02

High concentration alpha-glucosidase compositions for the treatment of Pompe disease

 #261
20170049804
2017-02-23

Fast acting joint relief formulations

 #262
20170049803
2017-02-23

Glycosaminoglycan composition and method of use for kidney stone removal

 #263
20170049802
2017-02-23

Methods and compositions for treating rosacea

 #264
20170049686
2017-02-23

Anti-aging formulation with stabilized Epigallo Catechin Gallate (ECGC)

 #265
20170049685
2017-02-23

Anti-aging formulation with stabilized ascorbic acid and other actives

 #266
20170042919
2017-02-16

Analogs of N-acetlyglucosamine and uses thereof

 #267
20170014462
2017-01-19

Bone and joint protection composition and use thereof

 #268
20160361370
2016-12-15

Method to prepare polysaccharides possessing protective activities on fatty liver disease

 #269
20160354476
2016-12-08

Targeted therapeutic nucleosides and their use

 #270
20160331798
2016-11-17

NATURAL PRODUCT INHIBITORS OF 3DG

 #271
20160324839
2016-11-10

Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones

 #272
20160317673
2016-11-03

Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

 #273
20160317480
2016-11-03

Composition and Method of Pain Relief, Reduction of Inflammation, Maintenance of Joints, and Soothing Muscle Soreness

 #274
20160317414
2016-11-03

Prebiotic oral care methods using a saccharide

 #275
20160310520
2016-10-27

METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS

 #276
20160303162
2016-10-20

Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin

 #277
20160303161
2016-10-20

Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin

 #278
20160296603
2016-10-13

Synergistic glycocalyx treatment compositions and methods

 #279
20160295885
2016-10-13

Formulation of complex carbohydrate for fodder

 #280
20160279158
2016-09-29

USE OF GLUCOSAMINE-ENRICHED PLANT COMPOSITIONS

 #281
20160263146
2016-09-15

PHARMACEUTICAL COMPOSITION COMPRISING MONOSACCHARIDE AND/OR POLYSACCHARIDE AND USES OF MONOSACCHARIDE AND POLYSACCHARIDE

 #282
20160257705
2016-09-08

Generation of glucosamine from plant material

 #283
20160256478
2016-09-08

Methods of modulating the sialylation of Angptl4

 #284
20160235774
2016-08-18

Anti-bacterial applications of poly-N-acetylglucosamine nanofibers

 #285
20160220524
2016-08-04

COMPOSITIONS OF SMALL MOLECULE THERAPEUTICS

 #286
20160207953
2016-07-21

Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

 #287
20160169889
2016-06-16

Diagnosis of respiratory tract infectious disease using urine specimens

 #288
20160166594
2016-06-16

Dietary Supplement Regimen for Improving Joint Support

 #289
20160158284
2016-06-09

Laser assisted wound healing protocol and system

 #290
20160158147
2016-06-09

Composition and method for orally administering one or more active agents to a pet

 #291
20160151400
2016-06-02

HYBRID SCFA-HYDROXYL-DERIVATIZED MONOSACCHARIDES, METHODS OF SYNTHESIS, AND METHODS OF TREATING DISORDERS

 #292
20160145291
2016-05-26

Therapeutic monosaccharide-based inhibitors of hexokinase and glucokinase for parasitic diseases, along with methods of their formation and use

 #293
20160123961
2016-05-05

Method for measuring cell-to-cell transmission of α-synuclein aggregates using bimolecular fluorescence complementation system and method for screening a substance for preventing or treating neurodegenerative disease using the same

 #294
20160096861
2016-04-07

Galactoside inhibitor of galectins

 #295
20160039838
2016-02-11

Aminoquinazoline derivatives and their salts and methods of use thereof

 #296
20160038531
2016-02-11

Fast acting joint relief formulations

 #297
20160038522
2016-02-11

Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis

 #298
20160022719
2016-01-28

Composition for buffered aminoalkyl glucosaminide phosphate compounds and its use for enhancing an immune response

 #299
20160022714
2016-01-28

O-GLCNACYLATION TREATMENT FOR ISCHEMIC BRAIN INJURY

 #300
20160022713
2016-01-28

Compositions and products for infectious or inflammatory diseases or conditions